New Key Statistics Module, Z-Score and F-Score
SZSE:000513 Key Ratios
Market Cap ¥ M | 33,664.90 |
Enterprise Value ¥ M | 25,833.31 |
P/E(ttm) | 19.17 |
PE Ratio without NRI | 17.15 |
Forward PE Ratio | -- |
Price/Book | 2.59 |
Price/Sales | 3.10 |
Price/Free Cash Flow | 12.48 |
Price/Owner Earnings | 31.09 |
Payout Ratio % | 0.67 |
Revenue (TTM) ¥ M | 12,259.00 |
EPS (TTM) ¥ | 2.13 |
Beneish M-Score | -2.93 |
10-y EBITDA Growth Rate % | 13.20 |
5-y EBITDA Growth Rate % | 12.70 |
y-y EBITDA Growth Rate % | 7.10 |
EV-to-EBIT | 9.96 |
EV-to-EBITDA | 9.96 |
PEG | 1.35 |
Shares Outstanding M | 927.65 |
Net Margin (%) | 16.15 |
Operating Margin % | 20.30 |
Pre-tax Margin (%) | 20.32 |
Quick Ratio | 1.82 |
Current Ratio | 2.06 |
ROA % (ttm) | 7.83 |
ROE % (ttm) | 14.14 |
ROIC % (ttm) | 19.91 |
Dividend Yield % | 3.92 |
Altman Z-Score | 3.95 |
SZSE:000513 Number of Guru Trades
SZSE:000513 Volume of Guru Trades
Gurus Latest Trades with SZSE:000513
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000513 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Livzon Pharmaceutical Group Inc Insider Transactions
No Available Data